RAB14

Ras-related protein Rab-14 · P61106 · RAB14 on Sugi Atlas →

0 patent compounds predicted against RAB14, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RAB14 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options PHASE3COMPLETED
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation PHASE2COMPLETED
BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC PHASE2COMPLETED
A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer PHASE1/PHASE2COMPLETED
NEO100 and High-Grade Meningioma PHASE2RECRUITING
Repurposing Chlorpromazine in the Treatment of Glioblastoma PHASE2UNKNOWN
Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC) PHASE2COMPLETED
Nilotinib in Huntington's Disease PHASE1UNKNOWN
Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder PHASE1WITHDRAWN
Identification of New Biomarkers of Insulin Resistance nanACTIVE_NOT_RECRUITING
Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients nanRECRUITING
Multi-Dimensional Genomic Dissection of Ring Chromosome 14 Syndrome nanACTIVE_NOT_RECRUITING
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial nanRECRUITING
Fox BioNet Project: LRRK2-002 nanCOMPLETED
A Multicentric European Study to Promote Clinical Trial Readiness for STXBP1-related Disorders nanRECRUITING
TSH Receptor Mutations Among a Consanguineous Community nanCOMPLETED
Clinical Genetics Branch Eligibility Screening Survey nanNOT_YET_RECRUITING
Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population nanCOMPLETED
Gait in Rare Diseases nanCOMPLETED
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients nanCOMPLETED
RASopathy Biorepository nanRECRUITING
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies nanRECRUITING
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) nanCOMPLETED
Parkinson's Families Project nanRECRUITING
Rolandic Epilepsy Genomewide Association International Study nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RAB14 binder may also engage these)

ProteinNameSimilarity
Q52NJ6 1.000 Q52NJ6 →
Q91V41 1.000 Q91V41 →
Q5R8Z8 1.000 Q5R8Z8 →
Q5ZKU5 1.000 Q5ZKU5 →
P61107 0.999 P61107 →
P36410 0.995 P36410 →
O01803 0.993 O01803 →
Q9SEH3 0.993 Q9SEH3 →
Q9CQD1 0.993 Q9CQD1 →
P29687 0.993 P29687 →
Q68EK7 0.992 Q68EK7 →
P61018 0.992 P61018 →
Q4R4R9 0.992 Q4R4R9 →
A0A125YY17 0.992 A0A125YY17 →
P18066 0.992 P18066 →
P28188 0.992 P28188 →
P61271 0.991 P61271 →
Q0IIG7 0.991 Q0IIG7 →
Q91ZR1 0.991 Q91ZR1 →
P40392 0.991 P40392 →
Q9FIF9 0.991 Q9FIF9 →
P46638 0.991 P46638 →
Q40191 0.991 Q40191 →
Q9FPJ4 0.990 Q9FPJ4 →
Q9SMQ6 0.990 Q9SMQ6 →
Q9SN68 0.990 Q9SN68 →
P61017 0.990 P61017 →
Q5F470 0.989 Q5F470 →
P17610 0.989 P17610 →
P31584 0.989 P31584 →